AMAXA BIOSYSTEMS

Amaxa Biosystems GmbH develops and commercializes gene transfer technologies and products. The company offers Nucleofector Technology, a transfection solution which enables the transfer of various substrates, such as DNA, RNA, or peptides into cells. It also offers transfection services; HiFect transfection reagent, the transfection reagent for standard cell lines; antibiotics for the treatment and prevention of mycoplasma and other microbial contaminants; Expression Vectors for the expression o... f bright fluorescent proteins and individual customer constructs in mammalian cells; and peptide Nucleofection and transfection control solutions. Amaxa Biosystems offers its solutions in Canada, China, Croatia, Greece, Hong Kong, Indonesia, Japan, Korea, Malaysia, Mexico, Portugal, Singapore, Spain, Taiwan, and Turkey. The company was founded in 1998 and is based in Cologne, Germany. As of July 2, 2008, Amaxa Biosystems GmbH operates as a subsidiary of Lonza Group AG.

#SimilarOrganizations #People #Financial #Website #More

AMAXA BIOSYSTEMS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Genetics Health Care

Founded:

1998-01-01

Address:

Cologne, Nordrhein-Westfalen, Germany

Country:

Germany

Website Url:

http://www.amaxa.com

Total Employee:

101+

Status:

Active

Contact:

49 221 991990

Total Funding:

Technology used in webpage:

SPF

Similar Organizations

bigdna-logo

Current Employees Featured

wolfgang-kintzel_image

Wolfgang Kintzel
Wolfgang Kintzel Vice President of Global Marketing and Sales @ Amaxa Biosystems
Vice President of Global Marketing and Sales

not_available_image

Dietmar Lenz
Dietmar Lenz Executive Officer @ Amaxa Biosystems
Executive Officer

Investors List

earlybird-venture-capital_image

Earlybird Venture Capital

Earlybird Venture Capital investment in Venture Round - Amaxa Biosystems

Official Site Inspections

http://www.amaxa.com

Host Informations
Whois Informations

Loading ...